A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
Many UAB physicians from a variety of specialties appear on the prestigious Newsweek Top Cancer Doctors 2015 list.
The Hugh Kaul Personalized Medicine Institute recently awarded two collaborative pilot implementation projects to advance precision medicine at UAB.
The award, considered the ANA’s highest and most prestigious, recognizes early- to mid-career neurologists and neuroscientists who have made outstanding basic and clinical scientific advances
Oh honored with lifetime award from the American Association of Neuromuscular and Electrodiagnostic Medicine.
A new surgical robot helps UAB physicians add a new technique for preparing for epilepsy surgery.
Haydeh Payami, Ph.D., a leading geneticist recruited to the UAB-Hudson Alpha Center for Genomic Medicine and UAB Personalized Medicine Institute, is exploring the protective power of coffee and nicotine — and the mysteries of the microbiome — in Parkinson’s disease.
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race.
UAB researchers find a chemical pathway — a glutamate transporter — that may be causing seizures and shorten survival rates for patients with brain tumors.